Table 3 Total Fatty acid profile of HCV patients (pre and post) in comparison of controls

C – 14:0

1.1 ± 3.2^a

2.8 ± 1.7^b

1.9 ± 0.7^c

C - 16 : 0

23.9 ± 5.3^a

26.6 ± 3.8^b

27.8 ± 2.3^c

C - 18 : 0

14.7 ± 5.4

15.4 ± 5.12

12.3 ± 3.1

C - 20 : 0

0.4 ± 1.1

0.3 ± 0.9

0.4 ± 0.8

C - 14 : 1

0.5 ± 0.9

0.3 ± 2.2

0.4 ± 0.4

C - 16 : 1

2.6 ± 2.2

3.2 ± 1.4

3.8 ± 1.1

C - 18 : 1

19.8 ± 4.6

19.6 ± 3.6

20.9 ± 1.8

C - 22 : 1

1.9 ± 1.4

2.7 ± 1.4

2.3 ± 0.8

C – 24 : 1

0.3 ± 0.7

ND

ND

C - 18 : 2

25.0 ± 5.4^a

20.9 ± 5.8^b

21.6 ± 4.1^c

C - 18 : 3

0.8 ± 1.3

0.3 ± 1.0

0.7 ± 0.9

C - 20 : 4

5.9 ± 2.1

5.1 ± 1.6

5.3 ± 0.8

C - 20 : 5

0.9 ± 1.7

0.6 ± 1.3

0.5 ± 0.9

C - 20 : 3

0.4 ± 0.6

0.2 ± 0.9

ND

C - 22 : 6

0.39 ± 0.7

ND

ND

C-18:1: C-18:0

1.3

1.3

1.7

C-16:1: C-16:0

0.1

0.2

0.3

PUFA: SFA

1.0

0.6

0.8